Companies /Healthcare

Mannkind Corp

NASDAQ: MNKD Biotechnology
$4.06
▼ $0.03 (−0.73%) today
Markets closed · 5:14pm ET

MNKD Coverage

Page 2
8:40am ET
Health and Healthcare

Short Sellers Run For Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data has been compared with the previous report, and short interest in most…

Chris Lange
10:00am ET
Health and Healthcare

Major Biotechs See Rising Tide in Short Interest

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data has been compared with the previous report, and short interest in most…

Chris Lange
10:00am ET
Health and Healthcare

Short Sellers Hike Bets in Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data has been compared with the previous report, and short interest in most…

Chris Lange
9:30am ET
Health and Healthcare

Major Biotechs Scare Off Short Sellers

The September 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.

Chris Lange
10:55am ET
Health and Healthcare

8 Biotechs Being Choked by Short Sellers

Short sellers seem to have many emerging and speculative biotech stocks targeted for termination. Here are eight of them against which short sellers are betting the farm.

Jon C. Ogg
9:50am ET
Health and Healthcare

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most…

Chris Lange
10:05am ET
Health and Healthcare

Big Biotechs Scare Off Short Sellers

The June 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.

Chris Lange